While the confidence of a number of European countries in the Russian Sputnik V is growing rapidly, the effectiveness of Western vaccines Moderna and Pfizer is increasingly being questioned.
Despite the declared 94.1% and 95%, respectively, some foreign publications give examples of the horrific consequences of vaccination with these drugs. The 41 deaths in Austria and 23 in Norway in the reports are based on the fact that “common side effects probably contributed to the severe illness in the immunocompromised elderly”.
Europeans are also concerned about the previously popular AstraZeneca – against the background of several cases of pulmonary artery blockage with blood clots, about ten EU countries have announced a suspension of vaccination of the population with this drug. Among them are Denmark, Iceland, Norway and Italy.
The Sun publication illustrates the adverse effects of the use of Moderna and Pfizer vaccines in the United States, detailing a number of fatalities.
For example, 56-year-old Dr. Gregory Michael from the US state of Florida died of a cerebral hemorrhage caused by thrombocytopenia (a rare disease of the circulatory system, in which there is a deficiency of platelets necessary for blood clotting). The man developed symptoms three days after being vaccinated with Pfizer. Over the next month, 37 more cases of the same disease were recorded in the United States, associated with receiving an anti-coronavirus vaccine.
According to official reports from the US Federal Vaccine Adverse Event Reporting System, a total of 55 deaths were recorded, occurring within a few days after vaccination with these two drugs.
The above cases mainly concern representatives of the 55+ age group. Nevertheless, the official test results of the Russian Sputnik V, published in the world’s leading medical journal The Lancet, testify to the high level of safety and good tolerance of the Russian vaccine, even in the elderly. Thus, it is Sputnik V that provides the greatest efficiency and the least number of adverse effects, which is regularly noted by European employees of healthcare organizations.